As of 2026-01-01, the Relative Valuation of Fate Therapeutics Inc (FATE) is (21.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.98 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -2279.4%.
The range of the Relative Valuation is (19.35) - (23.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 17.7x | 15.5x |
| Forward P/E multiples | 14.3x - 18.0x | 16.2x |
| Fair Price | (19.35) - (23.95) | (21.41) |
| Upside | -2069.4% - -2537.6% | -2279.4% |
| Date | P/E |
| 2025-12-30 | -0.73 |
| 2025-12-29 | -0.74 |
| 2025-12-26 | -0.74 |
| 2025-12-24 | -0.75 |
| 2025-12-23 | -0.72 |
| 2025-12-22 | -0.78 |
| 2025-12-19 | -0.78 |
| 2025-12-18 | -0.78 |
| 2025-12-17 | -0.78 |
| 2025-12-16 | -0.81 |
| 2025-12-15 | -0.83 |
| 2025-12-12 | -0.85 |
| 2025-12-11 | -0.82 |
| 2025-12-10 | -0.81 |
| 2025-12-09 | -0.78 |
| 2025-12-08 | -0.79 |
| 2025-12-05 | -0.80 |
| 2025-12-04 | -0.81 |
| 2025-12-03 | -0.80 |
| 2025-12-02 | -0.74 |
| 2025-12-01 | -0.76 |
| 2025-11-28 | -0.84 |
| 2025-11-26 | -0.81 |
| 2025-11-25 | -0.78 |
| 2025-11-24 | -0.80 |
| 2025-11-21 | -0.76 |
| 2025-11-20 | -0.74 |
| 2025-11-19 | -0.78 |
| 2025-11-18 | -0.75 |
| 2025-11-17 | -0.72 |
| 2025-11-14 | -0.71 |
| 2025-11-13 | -0.73 |
| 2025-11-12 | -0.77 |
| 2025-11-11 | -0.83 |
| 2025-11-10 | -0.81 |
| 2025-11-07 | -0.79 |
| 2025-11-06 | -0.77 |
| 2025-11-05 | -0.81 |
| 2025-11-04 | -0.88 |
| 2025-11-03 | -0.93 |
| 2025-10-31 | -1.00 |
| 2025-10-30 | -0.95 |
| 2025-10-29 | -0.99 |
| 2025-10-28 | -1.10 |
| 2025-10-27 | -1.15 |
| 2025-10-24 | -1.22 |
| 2025-10-23 | -1.12 |
| 2025-10-22 | -1.10 |
| 2025-10-21 | -1.13 |
| 2025-10-20 | -1.14 |